Long-Term Use of Gemfibrozil (Lopid®) in the Treatment of Dyslipidemia

Lewis, James E.
September 1982
Angiology;Sep1982, Vol. 33 Issue 9, p603
Academic Journal
This report describes the results of long-term treatment for blood lipid regulation with a new drug, gemfibrozil (Lopid®). During a short-term placebo-controlled phase, gemfibrozil had significantly reduced triglycerides, VLDL-cholesterol, and total LDL-cholesterol, and had significantly increased HDL-cholesterol and the HDL-cholesterol to total cholesterol ratio. It had not, however, greatly affected total cholesterol and LDL-cholesterol. In the long term phase of the study the improvement attained during the controlled phase was maintained. More important, the lipoprotein values that had not shown improvement in the controlled phase showed definite beneficial changes. The types and incidence of adverse reactions during the long term treatment were similar to those observed during the controlled period. The results of the study indicate that gemfibrozil is effective and relatively safe for the long term treatment of lipid irregularities.


Related Articles

  • Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study. Siok-Fong Chin; Ibahim, Johari; Makpol, Suzana; Hamid, Noor Aini Abdul; Latiff, Azian Abdul; Zakaria, Zaiton; Mazlan, Musalmah; Yusof, Yasmin Anum Mohd; Karim, Aminuddin Abdul; Ngah, Wan Zurinah Wan // Nutrition & Metabolism;2011, Vol. 8 Issue 1, p42 

    Background: Vitamin E supplements containing tocotrienols are now being recommended for optimum health but its effects are scarcely known. The objective was to determine the effects of Tocotrienol Rich Fraction (TRF) supplementation on lipid profile and oxidative status in healthy older...

  • Dietary intake and blood lipid profile in overweight and obese schoolchildren. Madalena Rinaldi, Ana Elisa; Prado de Oliveira, Erick; Moreto, Fernando; Fernanda Costa Pinto Gabriel, Gleice; Eduardo Corrente, Jos‚; Carlos Burini, Roberto // BMC Research Notes;2012, Vol. 5 Issue 1, p598 

    Background: The high blood lipid levels and obesity are one of the main risk factors for cardiovascular diseases, and the atherosclerotic process begins in childhood. Some environmental factors are supposed to be involved in this relationship, such as dietary factors. This study aimed to...

  • Dual HDL/total cholesterol test: a single-tube, homogeneous assay for sequential measurement of HDL cholesterol and total cholesterol. Sampson, M. L.; Csako, G.; Remaley, A. T. // Annals of Clinical Biochemistry;Jul2000, Vol. 37 Issue 4, p479 

    The quantitation of cholesterol in lipoprotein subfractions is valuable in estimating the risk for coronary artery disease, but requires multiple tests. We describe a relatively simple procedure, referred to as the dual HDL/total cholesterol (DHT) assay, which allows the sequential measurement...

  • The Effect of a Plant-Based Diet on Plasma Lipids in Hypercholesterolemic Adults. Gardner, Christopher D.; Coulston, Ann; Chatterjee, Lorraine; Rigby, Alison; Spiller, Gene; Farquhar, John W. // Annals of Internal Medicine;5/3/2005, Vol. 142 Issue 9, p725 

    Background: A variety of food combinations can be used to meet national U.S. guidelines for obtaining 30% of energy or less from total fat and 10% of energy or less from saturated fat. Objective: To contrast plasma lipid responses to 2 low-fat diet patterns. Design: Randomized clinical trial....

  • Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal. Clifton, P. M.; Noakes, M.; Sullivan, D.; Erichsen, N.; Ross, D.; Annison, G.; Fassoulakis, A.; Cehun, M.; Nestel, P. // European Journal of Clinical Nutrition;Mar2004, Vol. 58 Issue 3, p503 

    OBJECTIVE:: To measure the relative effects of each of four phytosterol ester-enriched low-fat foods (bread, breakfast cereal, milk and yoghurt) on serum lipids, plasma phytosterols and carotenoids. DESIGN:: Three research centres undertook a randomised, incomplete crossover, single-blind study...

  • Suppressive Effect of Simvastatin on Intramural Small Coronary Arterial Lesions in Cholesterol-Fed Rabbits. Kato, Hiroyuki; Okada, Ryuuichirou; Oogushi, Kazuhisa; Emura, Sei; Kishikawa, Hayato; Kawazoye, Seiji; Fukuoka, Mami; Takashima, Toshinobu; Ohmori, Keizo // Angiology;Mar1998, Vol. 49 Issue 3, p211 

    The aim of this study was to examine the suppressive effect of simvastatin on intramural coronary arterial lesions in cholesterol-fed rabbits. In one experiment, six groups of rabbits were fed laboratory chow alone or with added 0.1%, 0.2%, 0.3%, 0.5% or 1.0% cholesterol for 16 weeks. In another...

  • Effect of Dietry Oat and Wheat Bran on Biochemical Changes in Rats Fed High Fat-High Cholesterol Diets. Aly, Nahla H. // Journal of Applied Sciences Research;Jan2012, Vol. 8 Issue 1, p598 

    The purpose of this study aims to examine the efficiency of using either oat or wheat bran (5 or 10%) on the prevention of hyperlipidemia, hypercholesterolemia induced in rats fed with High Fat-High Cholesterol (HFHC) diets. Sixty adult male albino rats were divided into six groups: (G1) normal...

  • Cholesterol Potentiates �-Amyloid-Induced Toxicity in Human Neuroblastoma Cells: Involvement of Oxidative Stress. Patricia Ferrera; Octavio Mercado-G�mez; Mart�n Silva-Aguilar; Mahara Valverde; Clorinda Arias // Neurochemical Research;Aug2008, Vol. 33 Issue 8, p1509 

    Abstract��Alterations in brain cholesterol concentration and metabolism seem to be involved in Alzheimer�s disease (AD). In fact, several experimental studies have reported that modification of cholesterol content can influence the expression of the amyloid precursor protein (APP)...

  • False negative results in the Roche assay for HDL-cholesterol. Bakker, Andries J; Zijlstra, Appie; Leemhuis, Marten P // Annals of Clinical Biochemistry;Sep2003, Vol. 40 Issue 5, p572 

    Measurement of HDL-cholesterol is important in the risk evaluation of cardiovascular disease. Recently, we encountered a 61-year-old man with a negative result for HDL-cholesterol using the Roche assay. Further analysis revealed that this patient had a monoclonal Ig type IgMκ, with an...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics